Cambridge Antibody Technology

Cambridge Antibody Technology Group PLC has developed a technology for the rapid isolation of human monoclonal antibodies. It provides Humira, an antibody for the treatment of rheumatoid arthritis. The company's products are used in the development of antibody-based human therapeutics and the drug discovery process. Cambridge Antibody also has licensing and collaboration agreements with pharmaceutical and technology companies worldwide.